Breckenridge Pharmaceutical, Inc. Recalls
3 recalls on record in the United States
drugs: 3
drugs
Class II
2026-05-13
Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release Capsules USP, 60mg, Rx Only, 90-c
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
View recall details →
drugs
Class II
2026-06-17
Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release Capsules, USP, 60mg, packaged in
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
View recall details →
drugs
Class II
2026-06-17
Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release Capsules, USP, 30mg, 1000 Capsule
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
View recall details →